"Naša spoločnosť poskytuje komplexné služby v oblasti urologickej a onkourologickej starostlivosti od 1.júna 2004. Veríme, že sa pridáte k stovkám až tisíckam našich pacientov a sami sa presvedčíte, že aj na Slovensku je možné poskytovať perfektnú a profesionálnu zdravotnú starostlivosť. Naša spoločnosť disponuje najmodernejšou prístrojovou technikou a v oblasti diagnostiky a terapie postupuje podľa najnovších trendov a poznatkov. Prístroje ktorými vyšetrujeme alebo liečime pravidelne obnovujeme a disponujeme najnovším prístrojovým vybavením . Aktívne sa zúčastňujeme významných medzinárodných vedeckých projektov v oblasti urológie aj onkourológie."

During the past decade, Privatna urologicka ambulancia, s.r.o. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Privatna urologicka ambulancia, s.r.o." #1 sponsor was "Ferring Pharmaceuticals" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Futura Medical Developments Ltd." with 1 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Privatna urologicka ambulancia, s.r.o." #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Privatna urologicka ambulancia, s.r.o." are "Prostate Cancer" (3 trials), "Cancer" (1 trials), "Clostridium Difficile Infection" (1 trials), "Erectile Dysfunction" (1 trials) and "Metastatic Castration-resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Privatna urologicka ambulancia, s.r.o." in a lesser frequency.

Most popular intervention types in "Privatna urologicka ambulancia, s.r.o." are "Drug" (5 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apalutamide" (1 trials), "Clostridium difficile vaccine" (1 trials), "DCVAC/PCa" (1 trials) and "Darolutamide (Nubeqa, BAY1841788)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Privatna urologicka ambulancia, s.r.o." are 7 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Privatna urologicka ambulancia, s.r.o.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Privatna urologicka ambulancia, s.r.o., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Privatna urologicka ambulancia, s.r.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".